Israel Englander Dynavax Technologies Corp Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Millennium Management LLC holds 1,482,952 shares of DVAX stock, worth $18 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,482,952

Previous 1,568,553 5.46%

Holding current value

$18 Million

Previous $17.6 Million 6.21%

% of portfolio

0.01%

Previous 0.01%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$10.05 - $11.61 $860,290 - $993,827	-85,601 Reduced 5.46%	1,482,952 $16.5 Million
Q2 2024 Aug 14, 2024	BUY	$10.73 - $12.58 $16.8 Million - $19.7 Million	1,568,553 New	1,568,553 $17.6 Million
Q4 2023 Feb 14, 2024	BUY	$13.09 - $14.98 $3.62 Million - $4.14 Million	276,362 Added 72.33%	658,433 $9.2 Million
Q2 2023 Aug 14, 2023	SELL	$9.85 - $13.17 $1.18 Million - $1.58 Million	-120,299 Reduced 23.95%	382,071 $4.94 Million
Q1 2023 May 15, 2023	BUY	$9.44 - $11.88 $3.7 Million - $4.66 Million	392,066 Added 355.44%	502,370 $4.93 Million
Q4 2022 Feb 14, 2023	SELL	$10.27 - $13.29 $8.26 Million - $10.7 Million	-803,886 Reduced 87.93%	110,304 $1.17 Million
Q3 2022 Nov 14, 2022	BUY	$9.93 - $17.44 $7.02 Million - $12.3 Million	707,112 Added 341.47%	914,190 $9.54 Million
Q2 2022 Aug 15, 2022	SELL	$7.45 - $12.83 $11.1 Million - $19.2 Million	-1,494,031 Reduced 87.83%	207,078 $2.61 Million
Q1 2022 May 16, 2022	SELL	$9.75 - $14.44 $676,650 - $1 Million	-69,400 Reduced 3.92%	1,701,109 $18.4 Million
Q4 2021 Feb 14, 2022	BUY	$13.17 - $20.94 $18.6 Million - $29.6 Million	1,412,111 Added 394.01%	1,770,509 $24.9 Million
Q3 2021 Nov 15, 2021	SELL	$9.16 - $19.83 $68,480 - $148,249	-7,476 Reduced 2.04%	358,398 $6.89 Million
Q2 2021 Aug 16, 2021	SELL	$7.25 - $10.99 $3.37 Million - $5.11 Million	-465,306 Reduced 55.98%	365,874 $3.6 Million
Q1 2021 May 17, 2021	BUY	$4.57 - $11.18 $3.32 Million - $8.13 Million	727,016 Added 697.95%	831,180 $8.17 Million
Q4 2020 Feb 16, 2021	SELL	$3.73 - $5.6 $3.78 Million - $5.67 Million	-1,013,187 Reduced 90.68%	104,164 $464,000
Q3 2020 Nov 16, 2020	BUY	$4.32 - $11.7 $4.83 Million - $13.1 Million	1,117,351 New	1,117,351 $4.83 Million
Q2 2020 Aug 14, 2020	SELL	$2.94 - $9.1 $592,142 - $1.83 Million	-201,409 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$2.27 - $6.2 $334,098 - $912,516	-147,180 Reduced 42.22%	201,409 $711,000
Q4 2019 Feb 14, 2020	SELL	$3.46 - $6.93 $1.68 Million - $3.37 Million	-485,584 Reduced 58.21%	348,589 $1.99 Million
Q3 2019 Nov 14, 2019	SELL	$2.69 - $4.85 $3.74 Million - $6.74 Million	-1,389,128 Reduced 62.48%	834,173 $2.98 Million
Q2 2019 Aug 14, 2019	SELL	$3.65 - $7.89 $267,019 - $577,200	-73,156 Reduced 3.19%	2,223,301 $8.87 Million
Q1 2019 May 14, 2019	BUY	$7.08 - $12.09 $11.9 Million - $20.3 Million	1,681,527 Added 273.45%	2,296,457 $16.8 Million
Q4 2018 Feb 14, 2019	BUY	$8.14 - $13.28 $4.19 Million - $6.84 Million	514,736 Added 513.74%	614,930 $5.63 Million
Q3 2018 Nov 14, 2018	SELL	$11.85 - $16.0 $352,039 - $475,328	-29,708 Reduced 22.87%	100,194 $1.24 Million
Q2 2018 Aug 14, 2018	BUY	$15.15 - $20.75 $1.28 Million - $1.75 Million	84,254 Added 184.57%	129,902 $1.98 Million
Q1 2018 May 15, 2018	SELL	$14.65 - $19.9 $811,448 - $1.1 Million	-55,389 Reduced 54.82%	45,648 $906,000
Q4 2017 Feb 14, 2018	BUY	$17.3 - $24.08 $1.75 Million - $2.43 Million	101,037	101,037 $1.89 Million

Others Institutions Holding DVAX

# of Institutions

273

Shares Held

130M

Call Options Held

451K

Put Options Held

203K

View Full List

About DYNAVAX TECHNOLOGIES CORP

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.54B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

More about DVAX

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account